Release Therapeutics is a private BioMedTech company on a mission to treat genetic diseases of the CNS without gene therapy.
Release Therapeutics has raised $3.9M in total funding. The most recent round was Seed. The last funding was announced in August 2024.
Release Therapeutics is headquartered in Geneva, Switzerland.
Release Therapeutics is a private BioMedTech company on a mission to treat genetic diseases of the CNS without gene therapy.
Release Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Release Therapeutics — Funding & Investors." VCBacked, August 6, 2024, https://www.vcbacked.co/company/release-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Release Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/release-therapeutics
{{cite web |title=Release Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/release-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated